These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2831249)

  • 1. HLA antigens in the Guillain-Barré syndrome.
    Winer JB; Briggs D; Welsh K; Hughes RA
    J Neuroimmunol; 1988 Apr; 18(1):13-6. PubMed ID: 2831249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunopathology of Guillain-Barré syndrome.
    Saida K
    Curr Opin Neurol; 1996 Oct; 9(5):329-33. PubMed ID: 8894406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA typing and Guillain-Barré syndrome.
    Latovitzki N; Suciu-Foca N; Penn AS; Olarte MR; Chutorian AM
    Neurology; 1979 May; 29(5):743-5. PubMed ID: 571573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection.
    Rees JH; Vaughan RW; Kondeatis E; Hughes RA
    J Neuroimmunol; 1995 Oct; 62(1):53-7. PubMed ID: 7499492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association with HLA-DR, -DQ or -DP alleles in Guillain-Barré syndrome.
    Hillert J; Osterman PO; Olerup O
    J Neuroimmunol; 1991 Jan; 31(1):67-72. PubMed ID: 1984036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential distribution of HLA alleles in two forms of Guillain-Barré syndrome.
    Monos DS; Papaioakim M; Ho TW; Li CY; McKhann GM
    J Infect Dis; 1997 Dec; 176 Suppl 2():S180-2. PubMed ID: 9396707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome.
    Jacobs BC; van Doorn PA; Groeneveld JH; Tio-Gillen AP; van der Meché FG
    J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):641-3. PubMed ID: 9219756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute polyradiculoneuropathy of Guillain-Barré. Critical review of potential etiopathogeneses].
    Guadagnino M; Petitto F
    Riv Neurol; 1985; 55(6):402-23. PubMed ID: 3008302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA antigens in Guillain-Barré syndrome.
    Kaslow RA; Sullivan-Bolyai JZ; Hafkin B; Schonberger LB; Kraus L; Moore MJ; Yunis E; Williams RM
    Neurology; 1984 Feb; 34(2):240-2. PubMed ID: 6538019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome.
    Yuki N; Sato S; Fujimoto S; Yamada S; Tsujino Y; Kinoshita A; Itoh T
    Muscle Nerve; 1992 Aug; 15(8):968-9. PubMed ID: 1495517
    [No Abstract]   [Full Text] [Related]  

  • 11. [Guillain-Barré disease: a current treatment method using immunoglobulins].
    Kleyweg RP; van der Meché FG
    Ned Tijdschr Geneeskd; 1992 Oct; 136(40):1956-60. PubMed ID: 1328903
    [No Abstract]   [Full Text] [Related]  

  • 12. [Guillain-Barré syndrome complicating cytomegalovirus infection in an immunocompetent adult].
    Lecocq P; Majid S; Girard Buttaz I
    Rev Med Interne; 1995; 16(11):847-9. PubMed ID: 8570942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and epidemiologic features of Guillain-Barré syndrome.
    Hughes RA; Rees JH
    J Infect Dis; 1997 Dec; 176 Suppl 2():S92-8. PubMed ID: 9396689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.
    Ho TW; Mishu B; Li CY; Gao CY; Cornblath DR; Griffin JW; Asbury AK; Blaser MJ; McKhann GM
    Brain; 1995 Jun; 118 ( Pt 3)():597-605. PubMed ID: 7600081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of HLA associations in male and female patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
    McCombe PA; Csurhes PA; Greer JM
    J Neuroimmunol; 2006 Nov; 180(1-2):172-7. PubMed ID: 16935351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Class I and II antigens and levels of IgG antibodies in patients with infiltrative tuberculosis of the lungs].
    Nikolaian LT; Karapetian ET; Pospelov LE
    Probl Tuberk; 1989; (3):49-51. PubMed ID: 2786199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-antigens in Guillain-Barré syndrome.
    Hafez M; Nagaty M; Al-Tonbary Y; el-Shennawy FA; el-Mongui A; el-Sallab S; Attia S
    J Neurogenet; 1985 Sep; 2(4):285-90. PubMed ID: 4087075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A patient with Guillain-Barré syndrome in association with Campylobacter jejuni enteritis (PEN19:LIO7) in a patient with HLA-B52 antigen].
    Kaida K; Yuki N; Takahashi M; Kamakura K; Nagata N
    Rinsho Shinkeigaku; 1994 Jul; 34(7):733-5. PubMed ID: 7955736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into Campylobacter jejuni-induced Guillain-Barré syndrome from the Lewis rat model of experimental allergic neuritis.
    Vriesendorp FJ
    J Infect Dis; 1997 Dec; 176 Suppl 2():S164-8. PubMed ID: 9396704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA antigens in the Landry-Guillain-Barré syndrome and chronic relapsing polyneuritis.
    Stewart GJ; Pollard JD; McLeod JG; Wolnizer CM
    Ann Neurol; 1978 Sep; 4(3):285-9. PubMed ID: 718142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.